Cargando…
Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study
BACKGROUND: Oral squamous cell carcinoma (OSCC) represents the most common oral malignancy. Despite recent advances in therapy, up to 50% of the cases have relapse and/or metastasis. There is therefore a strong need for the identification of new biological markers able to predict the clinical behavi...
Autores principales: | Bacchiocchi, Roberta, Rubini, Corrado, Pierpaoli, Elisa, Borghetti, Giulia, Procacci, Pasquale, Nocini, Pier Francesco, Santarelli, Andrea, Rocchetti, Romina, Ciavarella, Domenico, Lo Muzio, Lorenzo, Fazioli, Francesca |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527016/ https://www.ncbi.nlm.nih.gov/pubmed/18673553 http://dx.doi.org/10.1186/1471-2407-8-220 |
Ejemplares similares
-
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
por: Sugioka, Koji, et al.
Publicado: (2012) -
In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008) -
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017) -
P-cadherin expression and survival rate in oral squamous cell carcinoma:an immunohistochemical study
por: Lo Muzio, Lorenzo, et al.
Publicado: (2005) -
Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)